Ireland
--:--IST
Latest
Clinical Trials in Norway / NCT05691166
Active, not recruiting Not applicable

Reducing Falls With Progressive Resistance Training for the Oldest Old Adults With Reduced Muscle Strength

NCT05691166 · tracked via the Priya Life Science Norway tracker
Phase
Not applicable
Started
2023-03-30
Last updated
2026-10-02

Condition(s) studied

SarcopeniaAging

Investigational drug(s) / intervention(s)

High-intensity progressive resistance trainingWritten physical activity guidance

High-intensity progressive resistance training: Twice-weekly high-intensity progressive resistance training for 12 months, delivered at community-based fitness centres. Both weekly sessions are supervised during the first 6 months; from month 6 onward, one session per week may be completed without direct supervision, provided at least one session per week remains supervised.

Written physical activity guidance: Participants receive a booklet containing Norway's current physical activity recommendations for older adults, including instructions for seven exercises intended to reduce fall risk.

Study summary

This study will investigate the effects of 12 months of high-intensity progressive resistance training compared with a control group on fall-rate in older adults with reduced muscle strength.

Eligibility

Sex
ALL
Min age
80 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Aged 80 years or older * Low muscular strength (grip strength: \<41.6 kg for males and \<23.4 kg for females \[from 18.09.2024\] or chair stand \>15 seconds) * Community-dwelling incl. independent senior housing * Ambulatory without supervision or physical assistance from another person. Assistive devices such as canes/crutches/walkers allowed. * Able to see and hear sufficiently to undertake assessments and partake in the planned exercise training. Exclusion Criteria: * Pre-existing diagnosis of dementia * Moderate or severe cognitive impairment (score \<18 on the Mini-Mental State Examination) * Living in institutional care * Non-ambulatory or requiring person or wheelchair to assist when walking * Degenerative neurological and neuromuscular disease/disorder significantly influencing gait and mobility (e.g. amyotrophic lateral sclerosis \[ALS\] and Parkinson's disease). * Amputation (other than toes) * Contraindications to resistance training * Unstable fracture * Inability to comply with study requirements * Currently undertaking progressive resistance training

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Circulation and Medical Imaging Trondheim Norway

More Norwegian University of Science and Technology trials in Norway

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05691166 on ClinicalTrials.gov ↗ ← All trials in Norway